Immediate Impact
64 standout
Citing Papers
NAFLD and NASH: etiology, targets and emerging therapies
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Works of Brendan Ryan being referenced
Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Brendan Ryan | 270 | 168 | 112 | 46 | 540 | |
| Nicholas Stevens | 260 | 197 | 140 | 57 | 603 | |
| John Stoop | 186 | 101 | 194 | 39 | 552 | |
| Ιoannis M. Dokas | 129 | 96 | 113 | 39 | 495 | |
| Leila Omidi | 150 | 60 | 99 | 48 | 581 | |
| Ahmad Soltanzadeh | 290 | 112 | 239 | 94 | 622 | |
| Filippo Marciano | 75 | 84 | 48 | 42 | 568 | |
| Yeng‐Horng Perng | 141 | 56 | 87 | 30 | 542 | |
| Susan L. Murray | 60 | 58 | 61 | 50 | 640 | |
| Sylvie Nadeau | 264 | 50 | 240 | 77 | 611 | |
| María del Carmen Pardo-Ferreira | 100 | 30 | 73 | 23 | 572 |
All Works
Login with ORCID to disown or claim papers
Loading papers...